Magnesium and ketamine are wellknown N-methyl-D-aspartic acid receptor antagonists. The aim of this study was to determine whether magnesium, in comparison with ketamine, attenuates tourniquet-induced hypertension and spinal c-fos mRNA expression. Rats were divided into four treatment groups: normal (baseline for c-fos mRNA expression); control (saline injection); magnesium injection; and ketamine injection. Arterial blood pressure and c-fos mRNA expression at 60 min were higher in the control than in the magnesium and ketamine groups.
Introduction
Tourniquet-induced hypertension (TIH) is generally defined as a progressive increase of more than 30% in arterial blood pressure after tourniquet inflation under general anaesthesia. 1,2 It is thought that unmyelinated, slow-conducting C fibres are probably responsible for tourniquet-induced pain and TIH. 3 Prolonged firing of C-fibre nociceptors causes the release of glutamate, which acts on N-methyl-D-aspartic acid (NMDA) receptors in the spinal cord. 4 Pre-operative administration of ketamine prevents TIH, suggesting the involvement of an NMDA receptor antagonist in the attenuation of TIH. 5 Magnesium, another DH Lee, DL Jee, SY Kim et al. Tourniquet-induced hypertension and magnesium sulphate NMDA receptor antagonist, might also relieve the C fibre-related TIH. It has a spinal site of analgesic action, 6 gates glutamateactivated channels, 7 and has been used in the treatment of neuropathic pain because of its action on the NMDA receptor. 8 Repeated noxious stimuli increase fos-like immunoreactivity in the spinal dorsal horn, 9 and spinal expression of immediate early gene expression has been used to evaluate the efficacy of transmission of noxious inputs at this level in acute noxious stimuli, although the correlation between nociception and gene expression in the spinal cord is not perfect. 10, 11 Expression of c-fos is decreased in response to the administration of ketamine in dorsal horn neurons after noxious stimuli. 12 -14 This study investigated the effect of the administration of magnesium before tourniquet inflation on the tourniquetinduced expression of spinal c-fos mRNA in rats and TIH in humans and rats, in comparison with ketamine treatment. To date, it has not been shown that magnesium attenuates spinal c-fos mRNA expression or hypertension due to tourniquet inflation.
Materials and methods

ANIMAL EXPERIMENTS
All experiments were performed in accordance with a protocol approved by the Institutional Animal Care and Use Committee of the College of Medicine, Yeungnam University, Republic of Korea. Male Sprague-Dawley rats (250 -300 g; Sam, Seoul, Korea) were selected and divided randomly into one of four groups: normal (baseline for c-fos mRNA expression); control; magnesium; and ketamine.
The animals were anaesthetized with a 50 mg/kg pentobarbital intraperitoneal injection. After adequate anaesthesia, the posterior lumbar spinal cord of the rats in the normal group was extracted by the technique described below and immediately sent to a laboratory for the assessment of c-fos mRNA expression. Measurements of c-fos mRNA from the normal group were used to determine all baseline values.
After immobilization with bandages on the experiment table, a 24-G intravenous catheter was inserted into the right common carotid artery of animals in the control, magnesium and ketamine groups. Heart rate and arterial blood pressure were monitored continuously with an MP 100™ (Biopac Systems, Santa Barbara, California, USA). Rats in the control, magnesium and ketamine groups were injected with 0.1 ml saline, 50 mg/kg magnesium sulphate or 1 mg/kg ketamine, respectively, through the right external jugular vein.
After each injection, approximately 10 min later when the arterial pressure and heart rate had stabilized, a tourniquet (1.5 cm × 12 cm) was applied to one thigh of each animal. The tourniquet was connected to an inflation device (C-Fusor 500™, Medex, Ohio, USA) and inflated to 250 mmHg. Arterial blood pressure and heart rate were recorded before tourniquet inflation (baseline) and 30 and 60 min after the start of tourniquet inflation. Thirty minutes after tourniquet inflation, an additional 30 mg/kg pentobarbital was given intraperitoneally and anaesthesia was maintained.
After recording haemodynamic parameters for 60 min, 10 ml of air was injected into the right common carotid artery and cardiac arrest was induced. The rats were decapitated immediately. The entire spinal cord of the rats in each group was expelled from the spinal canal by forcefully injecting cold saline at the sacral vertebral level. The posterior lumbar spinal cord was stored in liquid nitrogen at -80°C for analysis of c-fos mRNA expression.
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Northern blot analysis
To isolate RNA from the posterior lumbar spinal cord, the frozen samples were homogenized using sterile pestles and mortars. RNA was isolated from the tissues using Tri-Reagent ® (MRC, Cincinnati, Ohio, USA) according to the manufacturer's protocol. Electrophoresis was performed on the total RNA (10 µg) using 1% formaldehyde agarose gel and MOPS (3-morpholinopropanesulphonic acid) buffer (20 mmol/l MOPS, 5 mmol/l sodium acetate and 1 mmol/l ethylenediaminetetraacetic acid, pH 7.0). This was blotted onto a Nytran Plus ® membrane (Schleicher & Schuell, Keene, New Hampshire, USA) and crosslinked to the membrane by UV irradiation. Hybridizations were performed for 12 -18 h at 42°C using hybridization solution (0.25 mol/l sodium chloride, 1% sodium dodecyl sulphate [SDS], 50% formamide, 2 × Denhardt's solution, 100 mg/ml salmon sperm DNA and 5% dextran sulphate), the blots were washed with 2 × SSC (standard saline citrate)/0.5% SDS for 5 min at room temperature and washed twice with 0.5 × SSC/0.1% SDS for 15 min at 42°C. Autoradiography was carried out with Hyperfilm ®_ MP (Amersham, Buckinghamshire, UK) at -70°C using double intensifying screens. Complementary DNA probes for c-fos and glyceraldehyde phosphate dehydrogenase were labelled with P 32 by the Nick Translation ® system (Promega, Madison, Wisconsin, USA).
Real-time polymerase chain reaction
For quantification using the real-time polymerase chain reaction (PCR), 2 µg of total RNA was reverse-transcribed to cDNA. A 1 µl aliquot of cDNA was amplified by the DNA Engine Opticon ® 2 system (MJ Research, Boston, Massachusetts, USA) with 10 µl of DyNAmo™ HS, 2 × master mix solution (DyNAmo Hot Start DNA polymerase, SYBR Green I dye, optimized PCR buffer, 5 mmol/l magnesium chloride, dNTP [deoxynucleotide triphosphate] mix with dUTP [deoxyuridine triphosphate]), 2 µl of 2 µmol/l primer and distilled water to make 20 µl in total. Beta-2 microglobulin (β 2 M) was used as a housekeeping gene to normalize for RNA loading. The primers for c-fos were: forward primer, 5′-CCAAGCGGAGACAGATCAACTT-3′; reverse primer, 5′-TCCAGTTTTTCCTTC-TCTTTCAGTAGAT-3′. Each sample was analysed in triplicate using the ∆∆CT method (MJ Research).
CLINICAL STUDIES
This study was approved by the Institutional Ethics Committee of Yeungnam University Hospital and written informed consent was obtained from each patient. This clinical study was designed to confirm the effects of magnesium on TIH and to compare the efficacy with that of ketamine in humans. The patients studied had American Society of Anesthesiologist (ASA) Physical Status I -II, were aged 17 -64 years, and were scheduled for elective knee surgery under general anaesthesia, in which the use of a pneumatic tourniquet was planned. Patients meeting the following criteria were excluded from the study: hypermagnesaemia; known allergy to magnesium sulphate; any degree of heart block, hypertension, diabetes mellitus, cardiovascular diseases or kidney dysfunction; expected tourniquet inflation time shorter than 70 min; and exaggerated hypertensive response (systolic arterial pressure > 200 mmHg) during tourniquet inflation.
Each patient was pre-medicated with glycopyrrolate 0.2 mg intramuscularly 1 h before the operation. After the induction of anaesthesia with 0.05 mg/kg midazolam, 3 -5 mg/kg sodium thiopental and DH Lee, DL Jee, SY Kim et al. Tourniquet-induced hypertension and magnesium sulphate 0.1 mg/kg vecuronium intravenously, the trachea was intubated. Subsequently, the patients were randomly divided into three groups. The control group was given 3 ml saline intravenously; the magnesium group received 30 mg/kg magnesium sulphate slowly over 2 -3 min; and the ketamine group received 0.25 mg/kg ketamine.
Anaesthesia was maintained with sevoflurane 1.5 -2.5% and oxygen 2 l per min/ nitrous oxide 2 l per min. Opioids or other analgesics were not used during the observation period. Ventilator settings were adjusted to maintain normocapnia (end-tidal carbon dioxide 30 -35 mmHg). During anaesthesia, EKG lead II, noninvasive arterial pressure, heart rate, oxygen saturation, end-tidal carbon dioxide and end-tidal sevoflurane concentration were monitored (Multi Channel Anesthesia Monitor S/5™; Datex-Ohmeda, Beaverton, Oregon, USA). To maintain a similar depth of anaesthesia among the groups, the bispectral index (BIS ® ) value of the electroencephalogram (A-2000 BIS ® Monitor System; Aspect Medical Systems, Newton, Massachusetts, USA) was maintained at 40 ± 5. Fluid was administered in accordance with patient fasting, maintenance volume and blood loss.
Approximately 10 min after the administration of the study drug, the tourniquet was applied at the thigh level at 350 mmHg pressure and the operation was started. Arterial blood pressure and heart rate were measured before tourniquet inflation (baseline) and every 10 min until 70 min after the start of tourniquet inflation. The anaesthetist who measured arterial blood pressure and heart rate was unaware of the protocol. The number of patients who developed TIH, as defined by an increase in systolic arterial blood pressure greater than 30% of the baseline value at 70 min, was recorded.
After
surgery, glycopyrrolate and pyridostigmine were administered intravenously to reverse muscle relaxation and the tracheal tube was removed.
STATISTICAL ANALYSIS
Statistical analysis was performed with the SPSS ® 10.0.7 programme (SPSS Inc., Chicago, Illinois, USA). All data are presented as the mean ± SEM. Demographic data for the patients and real-time PCR data were compared among the groups using one-way analysis of variance (ANOVA) with the post hoc Scheffé test. The haemodynamic changes were compared with the baseline values and among the three groups by using two-way repeated-measures ANOVA with Tukey's post hoc test. The χ 2 test and Fisher's exact test were used to compare the number of patients with TIH. P-values < 0.05 were considered to be statistically significant.
Results
ANIMAL EXPERIMENTS
A total of 32 rats were assigned to the four groups (n = 8). No statistically significant differences were found among the control, magnesium and ketamine groups with respect to baseline arterial blood pressure and heart rate. Systolic and diastolic arterial blood pressures in the control group (149.0 ± 3.8 mmHg and 100.0 ± 4.8 mmHg, respectively) were significantly higher than those in the groups receiving magnesium (135.1 ± 1.8 mmHg and 85.1 ± 2.2 mmHg, respectively) and ketamine (138.3 ± 2.9 mmHg and 93.1 ± 3.9 mmHg, respectively) 60 min after tourniquet inflation (P < 0.05), with no significant difference between the magnesium and ketamine groups. However, systolic and diastolic arterial blood pressures were significantly higher (P < 0.05) at 60 min in all groups compared with baseline values (systolic and diastolic arterial blood pressures DH Lee, DL Jee, SY Kim et al. Tourniquet-induced hypertension and magnesium sulphate at baseline were as follows: control group, 118.3 ± 2.1 mmHg and 77.1 ± 1.1 mmHg, respectively; magnesium group, 123.1 ± 1.9 mmHg and 78.4 ± 2.1 mmHg, respectively; ketamine group, 122.8 ± 1.9 mmHg and 77.1 ± 1.7 mmHg, respectively). Among the three groups, there was no difference in heart rate at all time-points (Fig. 1) .
The results of the northern blot analysis showed that c-fos mRNA expression increased in the control group compared with those of the normal, magnesium and ketamine groups ( Fig. 2A ). Real-time PCR showed that c-fos mRNA expression was significantly higher in the control group (4.2 ± 0.6) than in the normal (1.0) (P < 0.01), magnesium (1.8 ± 0.3) (P < 0.05) and ketamine (2.2 ± 0.6) (P < 0.05) groups, with no significant difference among the normal, magnesium and ketamine groups (Fig. 2B ).
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CLINICAL STUDIES
Eighty-nine patients were enrolled and 81 patients completed the study. Eight patients were excluded from the analysis of the results because the tourniquet inflation time was shorter than 70 min (two in the control group, one in the magnesium group and three in the ketamine group) or an exaggerated hypertensive response (systolic arterial blood pressure > 200 mmHg) was seen during tourniquet inflation (two in the control group). We continued the study until we had an equal number of patients (27) in each group.
No statistically significant differences were found among the study groups with respect to the patients' demographic and baseline haemodynamic data, end-tidal sevoflurane concentration and BIS ® values (Table 1) . Systolic and diastolic arterial blood pressures in the control group 50, 60 and 70 min after tourniquet inflation (50 min, 141.9 ± 3.1 mmHg and 84.3 ± 2.5 mmHg, respectively; 60 min, 144.1 ± 3.0 mmHg and 85.9 ± 2.5 mmHg, respectively; 70 min, 148.3 ± 2.9 mmHg and 87.7 ± 2.5 mmHg, respectively) were significantly (P < 0.05) higher than those of the magnesium group (50 min, 131.2 ± 1.9 mmHg and 77.0 ± 2.1 mmHg, respectively; 60 min, 130.3 ± 2.3 mmHg and 76.6 ± 1.9 mmHg, respectively; 70 min, 129.8 ± 2.4 mmHg and 75.3 ± 1.9 mmHg, respectively) and the ketamine group (50 min, 131.9 ± 3.3 mmHg and 76.2 ± 2.4 mmHg, respectively; 60 min, 133.4 ± 3.3 mmHg and 76.1 ± 2.6 mmHg, respectively; 70 min, 132.8 ± 3.0 mmHg and 77.9 ± 2.3 mmHg, respectively), with no significant difference between the magnesium and ketamine groups. When DH Lee, DL Jee, SY Kim et al. Tourniquet-induced hypertension and magnesium sulphate compared with the baseline values (control group, 127.7 ± 2.1 mmHg and 76.0 ± 3.2 mmHg, respectively; magnesium group, 128.0 ± 3.4 mmHg and 75.3 ± 1.6 mmHg, respectively; ketamine group, 126.1 ± 1.7 mmHg and 75.0 ± 2.4 mmHg, respectively), systolic and diastolic arterial blood pressures increased significantly at 50, 60 and 70 min after tourniquet inflation only in the control group (P < 0.05). Heart rates were not different among the three groups (Fig. 3) .
The percentage of patients who developed TIH was significantly higher in the control group (62.9%) than in the magnesium group (22.2%) and ketamine group (18.5%) (P < 0.01). There was no significant difference between the magnesium and ketamine groups (Fig. 4) . 
Discussion
In the present study, the efficacies of the well-known NMDA receptor antagonists magnesium and ketamine in TIH during general anaesthesia were compared. As expected, c-fos mRNA expression was increased after tourniquet inflation and gene expression was equally attenuated by prophylactic intravenous administration of magnesium or ketamine in rats. Magnesium was also as effective as ketamine in suppressing TIH in rats and humans. It is difficult to determine the mechanism by which magnesium and ketamine attenuated TIH in this study. Decreased expression of spinal c-fos mRNA has been found to suppress TIH, and the mechanism of TIH may include NMDA receptor activation. 5 Wilson and Crews 15 reported that blockade of dorsal horn NMDA receptors attenuated the pressor reflex evoked by static contraction and muscle stretching. Taken together, these reports suggest that activation of spinal NMDA receptors might be involved in the tourniquet-induced increase in arterial blood pressure. Ketamine has been suggested to play a role as an NMDA antagonist in the suppression of TIH. 5, 16 If decreased spinal expression of c-fos mRNA indicates reduced pain transmission, 10,11 it might be reasonable to presume that magnesium and ketamine have a site of action in the spinal cord. Reduced pain transmission through NMDA receptor antagonism is one of the mechanisms that may explain these findings.
The potency of volatile anaesthetics is increased by non-competitive 17,18 and competitive 19 * Tourniquet-induced hypertension and magnesium sulphate consequently, the analgesic effects of NMDA antagonists such as ketamine and magnesium are likely to be increased in the presence of volatile anaesthetics. 20 In this clinical study using inhalational anaesthetics, there was no significant increase in arterial blood pressure during the maintenance of tourniquet inflation compared with baseline values in the magnesium and ketamine groups; however, in the animal study using intraperitoneal pentobarbital, the systolic and diastolic arterial blood pressures were significantly increased during tourniquet inflation compared with baseline values in the magnesium and ketamine groups. It is speculated that this might be due to interaction between a volatile anaesthetic and an NMDA receptor antagonist. However, this speculation may be flawed because the depth of anaesthesia was not standardized, given the anaesthetics used and the effect of species difference in anaesthesia between humans and the rats. Further investigation is needed. However, it was not possible to exclude the possibility that opioid receptors in the brain and spinal cord may be also responsible for these findings. Ketamine appears to act on opioid receptors in the brain and spinal cord to produce analgesia. 21 It has been suggested that a substance with a calcium channelblocking effect, such as magnesium, would probably have some antinociceptive properties at opioid receptors; 22 consequently, magnesium may interfere with calcium channels at the opioid receptors. It has been reported that the administration of an opioid receptor agonist suppressed the expression of c-fos in the spinal cord after nociceptive stimulation. 23 -25 Thus, intravenous magnesium and ketamine may decrease spinal c-fos mRNA expression and pain transmission, which could also explain the suppression of TIH in the present study.
Magnesium is not an analgesic, although it has been used for pain relief. Several investigators have reported that the perioperative intravenous administration of magnesium sulphate reduces intra-and post-operative analgesic requirements and that the administration of magnesium in these doses is safe. 26 -28 These reports suggest that magnesium may be used for patients who undergo orthopaedic surgery on the extremities using a tourniquet. In contrast, TIH is relatively unresponsive to supplementary analgesic administration or the level of anaesthesia. Furthermore, the increase in arterial pressure induced by tourniquet pain could be a risk factor in patients with pre-existing essential hypertension, ischaemic cardiac disease, or increased intracranial or intraocular pressure. Hence, it is important to prevent TIH before it occurs. This study suggests magnesium sulphate has some therapeutic potential for TIH.
A previous report showed that the preoperative dose of intravenous ketamine used in this study (0.25 mg/kg for the clinical investigation and 1 mg/kg for the animal study) was effective in the prevention of TIH. 5 In contrast, the optimal dose of magnesium has not been investigated in humans or laboratory animals, and so arbitrary doses were used (30 mg/kg for the clinical investigation and 50 mg/kg for the animal study).
Since the intra-and extracellular magnesium concentrations do not necessarily reflect the magnesium concentrations in other tissues in the body, measurement of intra-and extracellular magnesium concentrations does not help in assessing the optimal clinical dose of magnesium. 29 In addition, changes in the concentration of magnesium in the plasma and cerebrospinal fluid are not related; consequently plasma levels are not adequate DH Lee, DL Jee, SY Kim et al.
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to predict the increase in magnesium concentration in the cerebrospinal fluid. 30 Thus, the plasma concentrations of magnesium were not measured.
In conclusion, intravenous administration of magnesium before tourniquet inflation was found to be as effective as ketamine in the suppression of spinal c-fos mRNA expression in rats and TIH in rats and humans. This suppression seems to be due to the reduced pain transmission associated with magnesium and ketamine.
